Phage Therapy: Alternative to antibiotics when superbugs become immune
About this audiobook
What Is Phage Therapy
The therapeutic use of bacteriophages, also known as phage therapy, viral phage therapy, or phagotherapy, may be defined as the treatment of infectious diseases caused by harmful bacteria. This treatment technique arose at the beginning of the 20th century, but following the second world war, it was gradually supplanted by the use of antibiotics in most areas of the globe. Bacteriophages are a kind of virus that attach itself to bacterial cells and then inject their genome into the bacterial cell. Bacteriophages are also known as phages. The bacterial genome is successfully replaced by the genome of the virus, which results in the cessation of the bacterial infection. Because it is unable to replicate, the bacterial cell that is responsible for the infection instead creates extra phages. Phages are only effective against extremely specific bacterial species due to their high level of specificity.
How You Will Benefit
(I) Insights, and validations about the following topics:
Chapter 1: Phage therapy
Chapter 2: Antibiotic
Chapter 3: Antimicrobial resistance
Chapter 4: Bacteriophage
Chapter 5: Colistin
Chapter 6: Multiple drug resistance
Chapter 7: Pseudomonas aeruginosa
Chapter 8: Carbapenem
Chapter 9: Polypeptide antibiotic
Chapter 10: Steffanie A. Strathdee
Chapter 11: Enzybiotics
Chapter 12: Ceftolozane/tazobactam
Chapter 13: Phagoburn
Chapter 14: ESKAPE
Chapter 15: Cefiderocol
Chapter 16: Center for Innovative Phage Applications and Therapeutics
Chapter 17: Locus Biosciences
Chapter 18: Benjamin Chan
Chapter 19: Robert T. Schooley
Chapter 20: Martha Clokie
Chapter 21: Multidrug-resistant bacteria
(II) Answering the public top questions about phage therapy.
(III) Real world examples for the usage of phage therapy in many fields.
(IV) 17 appendices to explain, briefly, 266 emerging technologies in each industry to have 360-degree full understanding of phage therapy' technologies.
Who This Book Is For
Professionals, undergraduate and graduate students, enthusiasts, hobbyists, and those who want to go beyond basic knowledge or information for any kind of phage therapy.
About the author
Fouad Sabry is the former Regional Head of Business Development for Applications at HP in Southern Europe, Middle East, and Africa (SEMEA). Fouad has received his B.Sc. of Computer Systems and Automatic Control in 1996, dual masterâs degrees from University of Melbourne (UoM) in Australia, Master of Business Administration (MBA) in 2008, and Master of Management in Information Technology (MMIT) in 2010.
Fouad has more than 20 years of experience in Information Technology and Telecommunications fields, working in local, regional, and international companies, such as Vodafone and IBM in Middle East and Africa (MEA) region. Fouad joined HP Middle East (ME), based in Dubai, United Arab Emirates (UAE) in 2013 and helped develop the software business in tens of markets across Southern Europe, Middle East, and Africa (SEMEA) regions. Currently, Fouad is an entrepreneur, author, futurist, focused on Emerging Technologies, and Industry Solutions, and founder of One Billion Knowledgeable (1BK) Initiative.
